INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the preventive effect of Telmisartan(Micardis) versus
placebo control on the transition to overt nephropathy in patients with diabetic nephropathy
manifesting microalbuminuria associated with type II diabetes, and to evaluate the efficacy
and safety of Telmisart (Micardis, Gliosartan, Kinzal, Kinzalmono, Predxal, Pritor, Samertan,
Telmisartan) for diabetic nephropathy patients.